Résultats de la recherche - 2 results
Annual report Belgian Cystic Fibrosis Registry 2016
been a steady 14 Summ ar y increase in the prevalence of Achromobacter xylosoxidans from 5.9% in 2009 stabilizing at prevalence levels above 10.0% since 2012. Thanks to improved disease management ...
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
of direct costs. CONCLUSIONS: Haemophilia represents both an economic and health burden, especially regarding individual health on an individual patient level. Initiatives to counteract this burden ...